High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study.

PloS One
Joana RoloCONCORD Working Group

Abstract

Several studies have addressed the epidemiology of community-associated Staphylococcus aureus (CA-SA) in Europe; nonetheless, a comprehensive perspective remains unclear. In this study, we aimed to describe the population structure of CA-SA and to shed light on the origin of methicillin-resistant S. aureus (MRSA) in this continent. A total of 568 colonization and infection isolates, comprising both MRSA and methicillin-susceptible S. aureus (MSSA), were recovered in 16 European countries, from community and community-onset infections. The genetic background of isolates was characterized by molecular typing techniques (spa typing, pulsed-field gel electrophoresis and multilocus sequence typing) and the presence of PVL and ACME was tested by PCR. MRSA were further characterized by SCCmec typing. We found that 59% of all isolates were associated with community-associated clones. Most MRSA were related with USA300 (ST8-IVa and variants) (40%), followed by the European clone (ST80-IVc and derivatives) (28%) and the Taiwan clone (ST59-IVa and related clonal types) (15%). A total of 83% of MRSA carried Panton-Valentine leukocidin (PVL) and 14% carried the arginine catabolic mobile element (ACME). Surprisingly, we found a high genetic ...Continue Reading

References

Jan 6, 2001·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M ChungUNKNOWN Multilaboratory Project Collaborators
Nov 1, 2002·Journal of Clinical Microbiology·Keiko OkumaKeiichi Hiramatsu
Oct 9, 2004·Journal of Clinical Microbiology·Geoffrey W CoombsUNKNOWN Australian Group for Antimicrobial Resistance
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John S FrancisJohn G Bartlett
May 25, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M MiragaiaH de Lencastre
Feb 4, 2006·Journal of Clinical Microbiology·M Aires-de-SousaW Witte
Jun 1, 2006·The Journal of Antimicrobial Chemotherapy·Duarte C OliveiraHermínia de Lencastre
Jun 20, 2007·Antimicrobial Agents and Chemotherapy·Catarina MilheiriçoHermínia de Lencastre
Jul 20, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E M Stam-BolinkA V M Möller
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A ManzurJ Ariza
Sep 6, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ulrich NübelMark Achtman
Mar 12, 2009·Current Molecular Medicine·Ruud H Deurenberg, Ellen E Stobberingh
Jun 6, 2009·Journal of Clinical Microbiology·Mari KanervaOuti Lyytikäinen
Jun 13, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M DaskalakiF Chaves
Sep 2, 2009·Antimicrobial Agents and Chemotherapy·UNKNOWN International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC)
Jan 20, 2010·PLoS Medicine·Hajo GrundmannUNKNOWN European Staphylococcal Reference Laboratory Working Group
Mar 9, 2010·Lancet·Frank R DeLeoHenry F Chambers
Mar 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Binh An DiepHenry F Chambers
Mar 26, 2010·The Lancet Infectious Diseases·Jonathan A Otter, Gary L French
Jun 12, 2010·Journal of Medical Microbiology·S M GreenS C Clarke
Nov 4, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T ConceiçãoH de Lencastre
Jan 12, 2011·Antimicrobial Agents and Chemotherapy·Jérôme RobertUNKNOWN ONERBA (Observatoire National de l'Epidémiologie de Résistance Bactérienne aux Antibiotiques)

❮ Previous
Next ❯

Citations

Aug 8, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A-K LarssonE Melander
Sep 13, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Teresa ConceiçãoMarta Aires-de-Sousa
May 7, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Teresa A FigueiredoRita G Sobral
Apr 3, 2013·Journal of Microbiological Methods·Forough L NowrouzianChristina Ahrén
Feb 21, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Shyamal Kumar PaulNobumichi Kobayashi
May 14, 2014·Journal of Infection and Public Health·Eileen HuangPeter M Rabinowitz
Jul 6, 2014·The Journal of Antimicrobial Chemotherapy·Ana VindelEmilia Cercenado
Jun 25, 2013·The Journal of Antimicrobial Chemotherapy·Sandra RincónCesar A Arias
Apr 23, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A TavaresUNKNOWN CA-MRSA/MSSA working group
Oct 23, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mitsuyo KawaguchiyaNobumichi Kobayashi
Oct 1, 2013·Expert Review of Anti-infective Therapy·Bettina LöfflerGeorg Peters
Feb 7, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C GlasnerJ M van Dijl
Oct 31, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C GarciaO Denis
Dec 17, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·F Patrick O'HaraHeather Amrine-Madsen
Nov 26, 2015·Journal of Dairy Science·R BossH U Graber
Oct 2, 2015·The Journal of Antimicrobial Chemotherapy·D J HetemUNKNOWN MOSAR WP3 Study Group
Jan 8, 2014·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Stefanie WaldenburgerAnnette Kolb-Mäurer
Aug 21, 2015·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Yvonne AchermannHugo Sax
Oct 8, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Shigeru FujimuraAkira Watanabe
Jan 14, 2016·Journal of Medical Microbiology·Bich Ngoc Thi VuHeiman Frank Louis Wertheim
Mar 19, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Michal SteinEli Somekh
Jan 24, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·S FernandezM Mollerach
May 15, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A BiberG Regev-Yochay
Mar 20, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Tetsuo YamaguchiTetsuya Matsumoto
Feb 11, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Shirish BalachandraJonathan N Tobin
Nov 15, 2014·The Journal of Antimicrobial Chemotherapy·Ad C FluitRob J L Willems

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Electrophoresis

Software Mentioned

BURST
StaphType
Bionumerics

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.